Detalles de la búsqueda
1.
Initial COVID-19 severity influenced by SARS-CoV-2-specific T cells imprints T-cell memory and inversely affects reinfection.
Signal Transduct Target Ther;
9(1): 141, 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38811527
2.
Establishment of the First National Standard for Neutralizing Antibodies against SARS-CoV-2 XBB Variants.
Viruses;
16(4)2024 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38675896
3.
Progress and challenges in the clinical evaluation of immune responses to respiratory mucosal vaccines.
Expert Rev Vaccines;
23(1): 362-370, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38444382
4.
A superior heterologous prime-boost vaccination strategy against COVID-19: A bivalent vaccine based on yeast-derived RBD proteins followed by a heterologous vaccine.
J Med Virol;
96(3): e29454, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38445768
5.
Blended BA.5 infection within 8 days after a boosted bivalent mRNA vaccination strengthens and lengthens the host immunity.
J Med Virol;
96(3): e29544, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38511577
6.
Omicron breakthrough infected individuals show enhanced nasal antibody responses and preserved T cell responses against the EG.5.1 and BA.2.86.
J Med Virol;
96(3): e29537, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38497465
7.
Immune escape of BA.2.86 is comparable to XBB subvariants from the plasma of BA.5- and BA.5-XBB-convalescent subpopulations.
J Med Virol;
96(1): e29417, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38258345
8.
Dynamic immune landscape in vaccinated-BA.5-XBB.1.9.1 reinfections revealed a 5-month protection-duration against XBB infection and a shift in immune imprinting.
EBioMedicine;
99: 104903, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38064992
9.
Safety, tolerability, and immunogenicity of a CpG/Alum adjuvanted SARS-CoV-2 recombinant protein vaccine (ZR202-CoV) in healthy adults: Preliminary report of a phase 1, randomized, double-blind, placebo-controlled, dose-escalation trial.
Hum Vaccin Immunother;
19(2): 2262635, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37881130
10.
Safety, immunogenicity, and efficacy of an mRNA COVID-19 vaccine (RQ3013) given as the fourth booster following three doses of inactivated vaccines: a double-blinded, randomised, controlled, phase 3b trial.
EClinicalMedicine;
64: 102231, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37767190
11.
Safety and immunogenicity of heterologous boosting with orally aerosolised or intramuscular Ad5-nCoV vaccine and homologous boosting with inactivated vaccines (BBIBP-CorV or CoronaVac) in children and adolescents: a randomised, open-label, parallel-controlled, non-inferiority, single-centre study.
Lancet Respir Med;
11(8): 698-708, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37209700
12.
Safety, immunogenicity, and efficacy of the mRNA vaccine CS-2034 as a heterologous booster versus homologous booster with BBIBP-CorV in adults aged ≥18 years: a randomised, double-blind, phase 2b trial.
Lancet Infect Dis;
23(9): 1020-1030, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37216958
13.
Standardized neutralization antibody analytical procedure for clinical samples based on the AQbD concept.
Signal Transduct Target Ther;
8(1): 165, 2023 04 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37105999
14.
Establishment of national standard for anti-SARS-Cov-2 neutralizing antibody in China: The first National Standard calibration traceability to the WHO International Standard.
Front Immunol;
14: 1107639, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36865542
15.
SARS-CoV-2 epitope-specific T cells: Immunity response feature, TCR repertoire characteristics and cross-reactivity.
Front Immunol;
14: 1146196, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36969254
16.
Xanthones from securidaca inappendiculata antagonizes the anti-rheumatic effect of methotrexate by inhibiting reduced folate carrier 1.
Immunopharmacol Immunotoxicol;
45(1): 16-25, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35850595
17.
Heterologous Omicron-adapted vaccine as a secondary booster promotes neutralizing antibodies against Omicron and its sub-lineages in mice.
Emerg Microbes Infect;
12(1): e2143283, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36377297
18.
Development of SARS-CoV-2 animal vaccines using a stable and efficient NDV expression system.
J Med Virol;
95(1): e28237, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36258299
19.
Virus infection pattern imprinted and diversified the differentiation of T-cell memory in transcription and function.
Front Immunol;
14: 1334597, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38264657
20.
SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants.
Cell Discov;
8(1): 136, 2022 Dec 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36543767